Journals A-Z
All Subjects
Free Journals
sciepub.com
American Journal of Pharmacological Sciences
ISSN (Print): 2327-6711 ISSN (Online): 2327-672X Website: https://www.sciepub.com/journal/ajps Editor-in-chief: Srinivas NAMMI
Open Access
Journal Browser
Go
Issue 5A, Volume 2
Article Metrics
  • 39480
    Views
  • 32093
    Saves
  • 7
    Citations
  • 55
    Likes
Export Article
American Journal of Pharmacological Sciences. 2014, 2(5A), 1-7
DOI: 10.12691/ajps-2-5A-1
Open AccessArticle

Solid Lipid Nanoparticles: A Potential Approach for Dermal Drug Delivery

Pratibha G. Kakadia1, and Barbara R. Conway1

1Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK

Pub. Date: September 22, 2014
View Full Text Full Text PDF Full Text ePUB

Cite this paper:
Pratibha G. Kakadia and Barbara R. Conway. Solid Lipid Nanoparticles: A Potential Approach for Dermal Drug Delivery. American Journal of Pharmacological Sciences. 2014; 2(5A):1-7. doi: 10.12691/ajps-2-5A-1

Abstract

Solid lipid nanoparticles (SLNs) have attracted increasing attention during recent years. Due to their unique size dependent properties, lipid nanoparticles offer possibilities to develop new therapeutics. The ability to incorporate drugs into nanoparticles offers a new prototype in drug delivery thus realizing the dual goal of both controlled release and site-specific drug delivery. Drug delivery to the skin is widely used for local and systemic delivery and has potential to be improved by application of nanoparticulate formulations. If investigated appropriately, solid lipid nanoparticles may open new opportunities in therapy of complex diseases which is difficult to treat.

Keywords:
solid lipid nanoparticles dermal delivery colloidal carriers

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 3

References:

[1]  Kaur, P.L., Guleri, T.K., “Topical gel: a recent approach for novel drug delivery”. Asia Journal of Biomedical & Pharmaceutical Sciences, 3(17). 1-5. 2013.
 
[2]  Haftek, M., Teillon, M. H., and Schmitt, D., “Stratum corneum, corneodesmosomes and ex vivo percutaneous penetration”. Microscopy Research and Technique, 43(3). 242-249. 1998.
 
[3]  Cevc, G. and U. Vierl, “Nanotechnology and the transdermal route: A state of the art review and critical appraisal”. Journal of Controlled Release, 141(3). 277-299. 2010.
 
[4]  Valenzuela, P., Simon, J.A., “Nanoparticle delivery for transdermal HRT”.Nanomedicine: NBM, 8. S83-S89. 2012.
 
[5]  Aryane, M.S., N. Sultana, and N. Sabah, “Fabrication of solid lipid nanoparticles for drug delivery”. Pakistan Journal of Pharmaceutical Sciences, 20(3). 251-259. 2007.
 
[6]  Pardeike, J., A. Hommoss, and R.H. Müller, “Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products”. International Journal of Pharmceutics, 366. 170-184. 2009.
 
[7]  Chimmiri, P., et al., “Solid lipid nanoparticles: a novel carrier for cancer therapy”.International Journal of Biological and Pharmaceutical Research, 3(3). 405-413. 2012.
 
[8]  Ekambaram, P., et al., “Solid lipid nanoparticles: a review”.Scientific Reviews and Chemical Communications, 2(1). 80-102. 2012.
 
[9]  Sinha, V.R. and M. Kaur, “Permeation enhancers for transdermal drug delivery”.Drug Development and Industrial Pharmacy, 26(11). 1131-1140. 2000.
 
[10]  Rupenganta, A., et al., “Solid lipid nanoaprticles- a versatile carrier system”. Journal of Pharmacy Research, 4(7). 2069-2075. 2011.
 
[11]  Fahr, A. and X. Liu, “Drug delivery strategies for poorly water soluble drugs”. Expert Opinion on Drug Delivery, 4(4). 403-416. 2007.
 
[12]  Garud, A., D. Singh, and N. Garud, “Solid lipid nanoparticles: method, characterization and applications”. Inernational Current Pharmaceutical Journal, 1(11). 384-393. 2012.
 
[13]  Kamble, M.S., et al., “Solid lipid nanoparticles and nanostructured lipid carriers - an overview”. International Journal of Pharmaceutical, Chemical and and Biological Sciences,2(4). 681-691. 2012.
 
[14]  Trotta, M., F. Debernardi, and O. Caputo, “Preparation of Solid lipid nanoparticles by a solvent emulsification-diffusion technique”.International Journal of Pharmaceutics, 257. 153-160. 2003.
 
[15]  Yadav, N., S. Khatak, and S. Sara, “Solid lipid nanoparticles: a review”.International Journal of Applied Pharmaceutics, 5(2). 8-18. 2013.
 
[16]  De Labouret, A., et al., “Application of an original process for obtaining colloidal dispersion of coating polymers- Preparation, Charcterization, Industrial scaling up”. Drug Development Industrial Pharmacy, 21. 229-241. 1995.
 
[17]  Freitas, C. and R.H. Müller, “Spray drying of solid lipid nanoparticles”. European Journal of Pharmaceutics and Biopharmaceutics, 46. 145-151. 1998.
 
[18]  Patel, D., et al., “Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation”. Scientia Pharmaceutica, 80(3). 749-764. 2012.
 
[19]  Das, S. and A. Chaudhury, “Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery”. American Association of Pharmaceutical Scientists PharmSciTech, 12(1). 62-67. 2011.
 
[20]  Waghmare, A.S., et al., “Solid lipid nanoparticles: a promising drug delivery”. Inernational Research Journal of Pharmacy, 3(4). 100-107. 2012.
 
[21]  Sinha, V.R., et al., “Solid lipid nanoparticles (SLN’S) – trends and implications in drug targeting”. International Journal of Advances in Pharmaceutical Sciences, 1. 12-238. 2010.
 
[22]  Reithmeier,H., J. Herrmann, and A. Gopferich, “Development and characterization of lipid microparticles as a drug carrier for somatostatin”. International Journal of Pharmaceutics, 218. 133-143. 2001.
 
[23]  Charcosset, C., A. EI-Harati, and H. Fessi, “Preparation of solid lipid nanoparticles using a membrane contactor”. Journal of Controlled Release, 108. 112-120. 2005.
 
[24]  Abdelwahed, W., et al., “Freeze-drying of nanoparticles: formulation, process and storage considerations”. Advanced Drug Delievery Review, 58(15). 1688-713. 2006.
 
[25]  Loxley, A., “Solid lipid nanoparticles for delivery of pharmaceutical active”. Drug Delivery Technology, 9(8). 2009.
 
[26]  Wolfgang, M. and K. Madar, “Solid lipid nanoparticles production, characterization and applications”. Advanced Drug Delivery Review, 47. 165-196. 2001.
 
[27]  Kakadia, P., et al. “Topical drug delivery of nanoencapsulated triclosan”. in 41st Annual Meeting & Exposition of the Controlled Release Society. Chicago.
 
[28]  Moddaresi, M., et al., “The role of vehicle-nanoparticle interactions in topical deug delivery”.International Journal of Pharmaceutics, 400(1-2). 176-182. 2010.
 
[29]  Luo, Y., et al., “Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability”. Journal of Controlled Release, 114. 53-59. 2006.
 
[30]  Nair, R., et al., “Recent advances in solid lipid nanoparticle based drug delivery systems”.Journal of Biomedical Sciences and Research, 3(2). 368-384. 2011.
 
[31]  Kamble, V.A., D.M. Jagadle, and V.J. Kadam, “Solid lipid nanoparticles as drug delivery system”.International Journal of Pharmaceutics and Biopharmaceutics, 1(3). 1-9. 2010.
 
[32]  Mukherjee, S., S. Ray, and R.S. Thakur, “Solid lipid nanoparticles (SLN): a modern formulation approach in drug delivery system”.Indian Journal of Pharmaceutical Sciences, 71(4). 349-358. 2009.
 
[33]  Gomez, M.V., et al., “Nanoparticles size determination by 1H NMR spectroscopy”.Journal of the Americal Chemical Society, 131(41). 14634-14635. 2009.
 
[34]  Verma, V.K. and A. Ram, “Preparation, characterization and in-vitro release of piroxicam-loaded solid lipid nanoparticles”. International Journal of Pharmaceutical Sciences and Nanotechnology, 3(3). 1136-1143. 2010.
 
[35]  Wang, J.W., et al., “Preparation and quality evaluation of oleanolic acid-loaded solid lipid nanoparticles”. Journal of Fourth Military Medical University, 28. 472-472. 2007.
 
[36]  Konrádsdóttir, F., et al., “Drug targeting to the hair follicles: a cyclodextrin-based drug delivery”. American Association of Pharmaceutical Scientists PharmSciTech, 10(1). 266-269. 2009.
 
[37]  Jenning, V., et al., “Vitamin A loaded solid lipid nanopartilces for topical use: occlusive properties and drug targeting to the upper skin”. European Journal of Pharmaceutics and Biopharmaceutics, 49. 211-218. 2000.
 
[38]  Schäfer-Korting, M., M. Wolfgang, and H. Korting, “Lipid nanoparticles for improved topical application of drugs for skin diseases”. Advanced Drug Delivery Review, 59. 427-443. 2007.
 
[39]  Wissing S.A., M.R.H., “Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration”. Journal of Controlled Release,81. 153-160. 2002.
 
[40]  Wiesenthal, A., et al., “Nanoparticles: small and mighty”. The International Journal of Dermatology, 50. 247 - 254. 2011.
 
[41]  Chena, H., et al., “Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting”. Journal of Controlled Release, 110(2). 296-306. 2006.
 
[42]  Wolff, K. and R.A. Johnson, “Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology, 6th edn. Part III—Diseases due to microbial agents”. 2009, New York: McGraw-Hill.
 
[43]  Maia, C.S., W. Mehnert, and M. Schaller, “Drug targeting by solid lipid nanoparticles for dermal use”. Journal of Drug Targeting, 10. 489-495. 2002.
 
[44]  Puglia, C., et al., “Lipid nanoparticles for prolonged topical delivery: an invitro and in vivo investigation”. International Journal of Pharmaceutics, 357. 295-304. 2008.
 
[45]  Mei, X., et al., “Comparison of toxicokinetic and tissue distribituion of triptolide-loaded solid lipid nanoparticles vs free triptolide in rates”. European Journal of Pharmaceutical Sciences, 47. 713-717. 2012.
 
Manuscript template